{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:21:36Z","timestamp":1784892096115,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Harvard Clinical and Translational Science Center","award":["UL1 TR001102"],"award-info":[{"award-number":["UL1 TR001102"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.schres.2018.12.006","type":"journal-article","created":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T06:38:04Z","timestamp":1545460684000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial"],"prefix":"10.1016","volume":"206","author":[{"given":"Andrea","family":"Bellavia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Centorrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0664-1194","authenticated-orcid":false,"given":"Linda","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2018.12.006_bb0005","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.12.006_bb0010","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","article-title":"The moderator\u2013mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations","volume":"51","author":"Baron","year":"1986","journal-title":"J. Pers. Soc. Psychol."},{"key":"10.1016\/j.schres.2018.12.006_bb0015","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1176\/appi.ajp.161.4.700","article-title":"Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits","volume":"161","author":"Centorrino","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.12.006_bb0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hup.2257","article-title":"Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics","volume":"27","author":"Centorrino","year":"2012","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.schres.2018.12.006_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.schres.2008.07.006","article-title":"Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study","volume":"105","author":"Daumit","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.12.006_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/ps.2009.60.1.125a","article-title":"CATIE findings revisited","volume":"60","author":"Davis","year":"2009","journal-title":"Psychiatr. Serv. Wash. DC"},{"issue":"12","key":"10.1016\/j.schres.2018.12.006_bb0035","first-page":"2090","article-title":"Effectiveness of switching antipsychotic medications. American","volume":"163","author":"Essock","year":"2006","journal-title":"J. Psychiatry"},{"key":"10.1016\/j.schres.2018.12.006_bb0040","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials","volume":"41","author":"Fusar-Poli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.12.006_bb0045","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.schres.2015.05.021","article-title":"The relationship between positive and negative syndrome scale (PANSS) schizophrenia severity scores and risk for hospitalization: an analysis of the CATIE schizophrenia trial","volume":"166","author":"Glick","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.12.006_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/sim.4780020219","article-title":"Tests for interaction in epidemiologic studies: a review and a study of power","volume":"2","author":"Greenland","year":"1983","journal-title":"Stat. Med."},{"key":"10.1016\/j.schres.2018.12.006_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajp.163.2.185","article-title":"Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics","volume":"163","author":"Heres","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.12.006_bb0060","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.schres.2011.01.022","article-title":"The association between weight change and symptom reduction in the CATIE schizophrenia trial","volume":"128","author":"Hermes","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.12.006_bb0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.11m07162","article-title":"Minimum clinically important difference in the positive and negative syndrome scale using data from the CATIE schizophrenia trial","volume":"73","author":"Hermes","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2018.12.006_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jech.2002.006361","article-title":"A definition of causal effect for epidemiological research","volume":"58","author":"Hern\u00e1n","year":"2004","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.schres.2018.12.006_bb0075","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000088921","article-title":"PANSS syndromes and quality of life in schizophrenia","volume":"38","author":"Karow","year":"2005","journal-title":"Psychopathology"},{"key":"10.1016\/j.schres.2018.12.006_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.12.006_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/jcp.0b013e3181602cf3","article-title":"Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting","volume":"28","author":"Kilzieh","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.12.006_bb0090","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.59.10.877","article-title":"Mediators and moderators of treatment effects in randomized clinical trials","volume":"59","author":"Kraemer","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2018.12.006_bb0095","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2018.12.006_bb0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1192\/bjp.bp.107.037218","article-title":"CATIE and CUtLASS: can we handle the truth?","volume":"192","author":"Lewis","year":"2008","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.schres.2018.12.006_bb0105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1176\/appi.ajp.2011.11010039","article-title":"The NIMH-CATIE schizophrenia study: what did we learn?","volume":"168","author":"Lieberman","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.12.006_bb0110","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2018.12.006_bb0115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2007.12.487","article-title":"Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE schizophrenia trial: prospective data from phase 1","volume":"101","author":"Meyer","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.12.006_bb0120","series-title":"Proceedings of the Seventeenth Conference on Uncertainty in Artificial Intelligence","first-page":"411","article-title":"Direct and indirect effects","author":"Pearl","year":"2001"},{"key":"10.1016\/j.schres.2018.12.006_bb0125","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3389\/fnins.2017.00741","article-title":"The complex relationship between antipsychotic-induced weight gain and therapeutic benefits: a systematic review and implications for treatment","volume":"11","author":"Raben","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.schres.2018.12.006_bb0130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00001648-199203000-00013","article-title":"Identifiability and exchangeability for direct and indirect effects","volume":"3","author":"Robins","year":"1992","journal-title":"Epidemiol. Camb. Mass."},{"key":"10.1016\/j.schres.2018.12.006_bb0135","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1176\/ajp.2006.163.12.2080","article-title":"Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia","volume":"163","author":"Rosenheck","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.12.006_bb0140","series-title":"Antipsychotic Trials in Schizophrenia: The CATIE Project","author":"Stroup","year":"2010"},{"key":"10.1016\/j.schres.2018.12.006_bb0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","article-title":"The National Institute of Mental Health clinical antipsychotic trials of intervention effectiveness (CATIE) project: schizophrenia trial design and protocol development","volume":"29","author":"Stroup","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.12.006_bb0150","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1176\/ajp.2007.164.3.415","article-title":"Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing Perphenazine: a CATIE study","volume":"164","author":"Stroup","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.12.006_bb0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/a0031034","article-title":"Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros","volume":"18","author":"Valeri","year":"2013","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.schres.2018.12.006_bb0160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/EDE.0b013e3181ba333c","article-title":"On the distinction between interaction and effect modification","volume":"20","author":"VanderWeele","year":"2009","journal-title":"Epidemiol. Camb. Mass."},{"key":"10.1016\/j.schres.2018.12.006_bb0165","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1467-9469.2010.00722.x","article-title":"Controlled direct and mediated effects: definition, identification and bounds","volume":"38","author":"Vanderweele","year":"2011","journal-title":"Scand. J. Stat."},{"key":"10.1016\/j.schres.2018.12.006_bb0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/EDE.0b013e3182781410","article-title":"Policy-relevant proportions for direct effects","volume":"24","author":"VanderWeele","year":"2013","journal-title":"Epidemiol. Camb. Mass."},{"key":"10.1016\/j.schres.2018.12.006_bb0175","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/EDE.0000000000000121","article-title":"A unification of mediation and interaction: a 4-way decomposition","volume":"25","author":"VanderWeele","year":"2014","journal-title":"Epidemiol. Camb. Mass."},{"key":"10.1016\/j.schres.2018.12.006_bb0180","series-title":"Explanation in Causal Inference: Methods for Mediation and Interaction","author":"VanderWeele","year":"2015"},{"key":"10.1016\/j.schres.2018.12.006_bb0185","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4310\/SII.2009.v2.n4.a7","article-title":"Conceptual issues concerning mediation, interventions and composition","volume":"2","author":"VanderWeele","year":"2009","journal-title":"Stat. Interface"},{"key":"10.1016\/j.schres.2018.12.006_bb0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1515\/em-2012-0010","article-title":"Mediation analysis with multiple mediators","volume":"2","author":"VanderWeele","year":"2014","journal-title":"Epidemiol. Methods"},{"key":"10.1016\/j.schres.2018.12.006_bb0195","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/sim.3491","article-title":"Sample size calculations for evaluating mediation","volume":"28","author":"Vittinghoff","year":"2009","journal-title":"Stat. Med."},{"key":"10.1016\/j.schres.2018.12.006_bb0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00002018-200124010-00005","article-title":"Bodyweight gain with atypical antipsychotics. A comparative review","volume":"24","author":"Wetterling","year":"2001","journal-title":"Drug Saf."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418306947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418306947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T15:40:24Z","timestamp":1720885224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418306947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":40,"alternative-id":["S0920996418306947"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.12.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}